126 related articles for article (PubMed ID: 20845106)
21. Lack of an association between a functional polymorphism in the interleukin-6 gene promoter and breast cancer risk: a meta-analysis involving 25,703 subjects.
Yu KD; Di GH; Fan L; Chen AX; Yang C; Shao ZM
Breast Cancer Res Treat; 2010 Jul; 122(2):483-8. PubMed ID: 20043205
[TBL] [Abstract][Full Text] [Related]
22. T29C polymorphism in the transforming growth factor beta1 gene and postmenopausal breast cancer risk: the Multiethnic Cohort Study.
Le Marchand L; Haiman CA; van den Berg D; Wilkens LR; Kolonel LN; Henderson BE
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):412-5. PubMed ID: 15006917
[TBL] [Abstract][Full Text] [Related]
23. Transforming-growth factor beta1 Leu10Pro polymorphism and breast cancer morbidity.
González-Zuloeta Ladd AM; Arias-Vásquez A; Siemes C; Coebergh JW; Hofman A; Witteman J; Uitterlinden A; Stricker BH; van Duijn CM
Eur J Cancer; 2007 Jan; 43(2):371-4. PubMed ID: 17035001
[TBL] [Abstract][Full Text] [Related]
24. IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls.
Qiu LX; Yao L; Yuan H; Mao C; Chen B; Zhan P; Xue K; Zhang J; Hu XC
Breast Cancer Res Treat; 2010 Aug; 122(3):867-71. PubMed ID: 20084546
[TBL] [Abstract][Full Text] [Related]
25. TGFbeta1 T29C polymorphism and cancer risk: a meta-analysis based on 40 case-control studies.
Wei BB; Xi B; Wang R; Bai JM; Chang JK; Zhang YY; Yoneda R; Su JT; Hua LX
Cancer Genet Cytogenet; 2010 Jan; 196(1):68-75. PubMed ID: 19963138
[TBL] [Abstract][Full Text] [Related]
26. Genetic variation in transforming growth factor-beta1 gene associated with increased risk of esophageal squamous cell carcinoma.
Wei YS; Xu QQ; Wang CF; Pan Y; Liang F; Long XK
Tissue Antigens; 2007 Dec; 70(6):464-9. PubMed ID: 17990985
[TBL] [Abstract][Full Text] [Related]
27. Lack of significant association between TGF-β1-590C/T polymorphism and breast cancer risk: a meta-analysis.
Huang Y; Hao Y; Li B; Xie J; Qian J; Chao C; Yu L
Med Oncol; 2011 Jun; 28(2):424-8. PubMed ID: 20349216
[TBL] [Abstract][Full Text] [Related]
28. Endothelial nitric oxide synthase (eNOS) 894 G>T polymorphism is associated with breast cancer risk: a meta-analysis.
Hao Y; Montiel R; Huang Y
Breast Cancer Res Treat; 2010 Dec; 124(3):809-13. PubMed ID: 20428939
[TBL] [Abstract][Full Text] [Related]
29. An updated meta-analysis on the association of TGF-β1 gene promoter -509C/T polymorphism with colorectal cancer risk.
Wang Y; Yang H; Li L; Xia X
Cytokine; 2013 Jan; 61(1):181-7. PubMed ID: 23084539
[TBL] [Abstract][Full Text] [Related]
30. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
31. NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis.
Zhang J; Qiu LX; Wang ZH; Wang JL; He SS; Hu XC
Breast Cancer Res Treat; 2010 Oct; 123(3):877-83. PubMed ID: 20180012
[TBL] [Abstract][Full Text] [Related]
32. Polymorphisms in TGF-beta1 gene and the risk of lung cancer.
Kang HG; Chae MH; Park JM; Kim EJ; Park JH; Kam S; Cha SI; Kim CH; Park RW; Park SH; Kim YL; Kim IS; Jung TH; Park JY
Lung Cancer; 2006 Apr; 52(1):1-7. PubMed ID: 16499994
[TBL] [Abstract][Full Text] [Related]
33. NBS1 8360G > C polymorphism is associated with breast cancer risk: a meta-analysis.
Wang Z; Cui D; Lu W
Breast Cancer Res Treat; 2010 Sep; 123(2):557-61. PubMed ID: 20143155
[TBL] [Abstract][Full Text] [Related]
34. Lack of association between the hOGG1 Ser326Cys polymorphism and breast cancer risk: evidence from 11 case-control studies.
Gu D; Wang M; Zhang Z; Chen J
Breast Cancer Res Treat; 2010 Jul; 122(2):527-31. PubMed ID: 20054639
[TBL] [Abstract][Full Text] [Related]
35. The MPO -463G>A polymorphism and cancer risk: a meta-analysis based on 43 case-control studies.
Chu H; Wang M; Wang M; Gu D; Wu D; Zhang Z; Tang J; Zhang Z
Mutagenesis; 2010 Jul; 25(4):389-95. PubMed ID: 20418356
[TBL] [Abstract][Full Text] [Related]
36. No association between a progesterone receptor gene promoter polymorphism (+331G>A) and breast cancer risk in Caucasian women: evidence from a literature-based meta-analysis.
Yu KD; Chen AX; Shao ZM
Breast Cancer Res Treat; 2010 Aug; 122(3):853-8. PubMed ID: 20076999
[TBL] [Abstract][Full Text] [Related]
37. The relationship between the TGF-beta1 gene -509C/T polymorphism and tubulointerstitial damage resulting from primary nephrotic syndrome.
Li Y; Liu FY; Peng YM; Li J; Sun L; Chen X; Duan SB; Ling GH; Guo N; Liu YH
Ren Fail; 2010 May; 32(4):420-7. PubMed ID: 20446778
[TBL] [Abstract][Full Text] [Related]
38. RAD51 135G>C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjects.
Wang Z; Dong H; Fu Y; Ding H
Breast Cancer Res Treat; 2010 Dec; 124(3):765-9. PubMed ID: 20396943
[TBL] [Abstract][Full Text] [Related]
39. Current evidence on the relationship between polymorphisms in the COX-2 gene and breast cancer risk: a meta-analysis.
Yu KD; Chen AX; Yang C; Qiu LX; Fan L; Xu WH; Shao ZM
Breast Cancer Res Treat; 2010 Jul; 122(1):251-7. PubMed ID: 20033767
[TBL] [Abstract][Full Text] [Related]
40. Association of a vascular endothelial growth factor gene 936 C/T polymorphism with breast cancer risk: a meta-analysis.
Yang DS; Park KH; Woo OH; Woo SU; Kim AR; Lee ES; Lee JB; Kim YH; Kim JS; Seo JH
Breast Cancer Res Treat; 2011 Feb; 125(3):849-53. PubMed ID: 20652396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
